Migraine

Eli Lilly

NCT06662383

Ages:

Reimbursement:

Trial Length:

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity (TRIUMPH-5)

    Sign Up For The Trial

    If you wish to participate in this trial and meet all the qualifications, please fill out the form below.